alternative lengthening telomeres renders cancer cells hypersensitive atr inhibitors 
cancer cells rely telomerase alternative lengthening telomeres alt pathway overcome replicative mortality alt mediated recombination prevalent subset human cancers yet whether can exploited therapeutically remains unknown loss chromatin-remodeling protein atrx associates alt cancers show atrx loss compromises cell-cycle regulation telomeric noncoding rna terra leads persistent association replication protein rpa telomeres dna replication creating recombinogenic nucleoprotein structure inhibition protein kinase atr critical regulator recombination recruited rpa disrupts alt triggers chromosome fragmentation apoptosis alt cells cell death induced atr inhibitors highly selective cancer cells rely alt suggesting inhibitors may useful treatment alt-positive cancers 
